Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison
Alzheimer's & Dementia · 2026-05 · 22 (5)
DOI: 10.1002/alz.71496 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 18.05.2026. Verfasst von Juan Antonio K Chong Chie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Connectome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Stark Neuroscience Research Institute.
Themen: Demenz
Abstract (Originalsprache)
Historically, imaging diagnostics in Alzheimer's disease (AD) have focused primarily on amyloid and tau accumulation; however, recent work suggests that neurometabolic and vascular dysregulation (MVD) may precede protein deposition and persist throughout the disease spectrum, preclinically and clinically. Translating these findings between human patients and preclinical mouse models remains challenging due to cross‐species differences. To address this, regional MVD phenotypes were identified using cerebral metabolism and blood flow, and region‐set enrichment analysis (RSEA) was conducted to assess brain functional category (BFC) changes based on metabolic variations, facilitating systematic cross‐species comparisons. Clinically, MVD showed progressive alterations across the AD spectrum, while mouse models demonstrated similar genotype‐ and age‐dependent changes. Although direct one‐to‐one regional correspondence is limited, RSEA revealed changes in comparable BFCs. Our findings suggest that imaging‐based MVD mapping and RSEAs can bridge species differences, offering a translational framework to support early diagnostics of AD, enhance disease stratification, and enable therapeutic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Wood College of Osteopathic Medicine, Marian University, Indianapolis, Indiana, USA.
- School of Electrical and Computer Engineering, Purdue University, Indianapolis, Indiana, USA.
- Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Juan Antonio K Chong Chie, Paul R Territo
Förderung
- NIA NIH HHS
- Stark Neuroscience Research Institute
Zitieren
APA
Chong Chie, J. A. K., Persohn, S. A., Simcox, O. R., Collins, A., Salama, P., Territo, P. R., & Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium (2026). Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison. Alzheimer's & Dementia, 22(5). https://doi.org/10.1002/alz.71496
Vancouver
Chong Chie JAK, Persohn SA, Simcox OR, Collins A, Salama P, Territo PR, et al. Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison. Alzheimer's & Dementia. 2026;22(5). doi:10.1002/alz.71496
BibTeX
@article{ChongChie2026,
author = {Chong Chie, Juan Antonio K and Persohn, Scott A and Simcox, Olivia R and Collins, Alyssa and Salama, Paul and Territo, Paul R and Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium, Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium},
title = {Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {5},
doi = {10.1002/alz.71496}
}
EUVIMED